Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Ocugen ( (OCGN) ) is now available.
On August 8, 2025, Ocugen, Inc. announced a Securities Purchase Agreement with Janus Henderson Investors for a registered direct offering of 20,000,000 shares of common stock and warrants to purchase an additional 20,000,000 shares. The offering, priced at $1.00 per share, is expected to generate gross proceeds of approximately $20 million, with potential additional proceeds of $30 million if the warrants are fully exercised. Noble Capital Markets, Inc. acted as the sole placement agent, and the offering is anticipated to close around August 11, 2025. This strategic move aims to bolster Ocugen’s financial position and support its ongoing development programs in gene therapies for blindness diseases.
The most recent analyst rating on (OCGN) stock is a Buy with a $8.00 price target. To see the full list of analyst forecasts on Ocugen stock, see the OCGN Stock Forecast page.
Spark’s Take on OCGN Stock
According to Spark, TipRanks’ AI Analyst, OCGN is a Neutral.
Ocugen’s overall stock score is primarily impacted by its financial challenges, with persistent losses and reliance on external funding. While technical indicators and valuation present additional concerns, positive developments in gene therapy and strategic partnerships provide some optimism for future growth.
To see Spark’s full report on OCGN stock, click here.
More about Ocugen
Ocugen, Inc. is a pioneering biotechnology leader specializing in gene therapies for blindness diseases. The company focuses on developing a breakthrough modifier gene therapy platform that addresses significant unmet medical needs for large patient populations through a gene-agnostic approach. Ocugen’s programs target inherited retinal diseases and blindness conditions affecting millions globally, such as retinitis pigmentosa, Stargardt disease, and geographic atrophy.
Average Trading Volume: 5,628,266
Technical Sentiment Signal: Hold
Current Market Cap: $291.8M
See more data about OCGN stock on TipRanks’ Stock Analysis page.